Surfactin suppresses osteoclastogenesis via the NF-κB signaling pathway, promotes osteogenic differentiation in vitro, and inhibits oestrogen deficiency-induced bone loss in vivo
- Resource Type
- Article
- Source
- In
International Immunopharmacology April 2023 117 - Subject
- Language
- ISSN
- 1567-5769